These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33527178)

  • 1. Clinical implications of thrombocytosis in acute phase Kawasaki disease.
    Park JH; Choi HJ
    Eur J Pediatr; 2021 Jun; 180(6):1841-1846. PubMed ID: 33527178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of intravenous immunoglobulin resistance and coronary artery aneurysm in patients with Kawasaki disease.
    Chantasiriwan N; Silvilairat S; Makonkawkeyoon K; Pongprot Y; Sittiwangkul R
    Paediatr Int Child Health; 2018 Aug; 38(3):209-212. PubMed ID: 29768976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Risk Prediction of Coronary Artery Lesions through the Novel Hematological Z-Values in 4 Chronological Age Subgroups of Kawasaki Disease.
    Cho HJ; Kim WY; Park SM; Lee JH; Shin HJ; Jang GY; Ha KS
    Medicina (Kaunas); 2020 Sep; 56(9):. PubMed ID: 32932823
    [No Abstract]   [Full Text] [Related]  

  • 5. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
    Tse SM; Silverman ED; McCrindle BW; Yeung RS
    J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of different doses of aspirin on the prognosis of Kawasaki disease.
    Wang J; Chen H; Shi H; Zhang X; Shao Y; Hang B; Xu Z; Rong X; Chu M; Qiu H
    Pediatr Rheumatol Online J; 2020 Jun; 18(1):48. PubMed ID: 32527316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood routine risk factors for coronary artery aneurysm in infants younger than 8 months with Kawasaki disease.
    Haiyan G; Jianming L; Suqian T; Dong Q; Shuang L; Jin Z
    BMC Pediatr; 2022 Jan; 22(1):29. PubMed ID: 34996405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Aspirin is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.
    Kuo HC; Lo MH; Hsieh KS; Guo MM; Huang YH
    PLoS One; 2015; 10(12):e0144603. PubMed ID: 26658843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal presentation of Kawasaki disease: A red flag for severe disease?
    Fabi M; Corinaldesi E; Pierantoni L; Mazzoni E; Landini C; Bigucci B; Ancora G; Malaigia L; Bodnar T; Di Fazzio G; Lami F; Valletta E; Cicero C; Biasucci G; Iughetti L; Marchetti F; Sogno Valin P; Amarri S; Brusa S; Sprocati M; Maggiore G; Dormi A; Lanzoni P; Donti A; Lanari M
    PLoS One; 2018; 13(9):e0202658. PubMed ID: 30180185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Count Variation and Risk for Coronary Artery Abnormalities in Kawasaki Disease.
    Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Shindo A; Kuwabara M; Makino N; Matsubara Y; Kosami K; Sasahara T; Belay ED
    Pediatr Infect Dis J; 2020 Mar; 39(3):197-203. PubMed ID: 31851145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.
    Qin L; Saumu MT; Wang H; Shi H; Hu X; Cheng P
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(3):348-50, 370. PubMed ID: 16201293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic study of Kawasaki disease and cases resistant to IVIG therapy in Thailand.
    Durongpisitkul K; Sangtawesin C; Khongphatthanayopthin A; Panamonta M; Sopontammarak S; Sittiwangkul R; Pongpanich B
    Asian Pac J Allergy Immunol; 2006 Mar; 24(1):27-32. PubMed ID: 16913186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Kawasaki disease: modified methylprednisolone regimen decreases coronary artery dilatation.
    Zhang M; Zheng Y; Li X; Yang S; Shi L; Li A; Liu Y
    Pediatr Res; 2022 May; 91(6):1542-1550. PubMed ID: 34021270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 942 cases of Kawasaki disease].
    Zhang W; Li Q; Zhao XD; Tang XM; Wang XG; Wang M; Wu DQ; Ou Q; Yang XQ
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):324-8. PubMed ID: 16780705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
    Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.
    Fabi M; Andreozzi L; Frabboni I; Dormi A; Corinaldesi E; Lami F; Cicero C; Tchana B; Francavilla R; Sprocati M; Bigucci B; Balsamo C; Valin PS; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Clin Rheumatol; 2021 Apr; 40(4):1507-1514. PubMed ID: 32936425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C; Yeung RS; Chahal N; McCrindle BW
    Pediatr Allergy Immunol; 2010 May; 21(3):515-21. PubMed ID: 20546528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical symptoms of patients with Kawasaki disease include smoldering fever.
    Iwasa M; Inukai S
    Pediatr Int; 2023; 65(1):e15541. PubMed ID: 36975765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.